海南双成药业股份有限公司 关于选举职工代表董事的公告

Core Viewpoint - The company, Hainan Shuangcheng Pharmaceutical Co., Ltd., has successfully completed the election of its sixth board of directors and the appointment of senior management personnel, ensuring compliance with relevant laws and regulations [1][41]. Group 1: Board Election - The sixth board of directors was elected during the employee representative meeting held on January 8, 2026, with LI JIANMING elected as the employee representative director [1][3]. - The board consists of 5 members, including 3 non-independent directors and 2 independent directors, ensuring that the number of employee representative directors does not exceed half of the total board members [41][42]. - The election of non-independent directors, including WANG CHENGDONG and WANG YINGPU, was approved with significant support, receiving 96.65% and 97.23% of the votes, respectively [10][11]. Group 2: Senior Management Appointments - LI JIANMING was reappointed as the General Manager, with his term aligned with the new board's term [30][31]. - Other senior management appointments include YUAN JIANLIN, YU XIAOFENG, YAO ZHONG, WANG SHIYIN, AI YIXIANG, LI HAIYAN, WANG RUI, and LI YUAN as Vice Presidents, and WANG XUGUANG as the Chief Financial Officer [31][41]. - The appointments of the board secretary and securities affairs representative were also confirmed, with YU XIAOFENG and LI FEN continuing in their roles [33][36]. Group 3: Shareholder Meeting Details - The first temporary shareholder meeting of 2026 was held on January 8, 2026, with 306 shareholders present, representing 52.16% of the total voting shares [7][8]. - The meeting was conducted in accordance with legal and regulatory requirements, with no resolutions being rejected [5][6]. - The legal opinions provided by Beijing Zhonglun Law Firm confirmed the legality and validity of the meeting's proceedings [20][21].